Wednesday, July 23, 2008
MethylGene stops enrolling new patients for trials of Hodgkin's lymphoma drug
MONTREAL - Cancer drug developer MethylGene Inc. (TSX:MYG) said Tuesday that it has temporarily halted the enrolment of new patients into clinical trials of its treatment for Hodgkin's lymphoma....More
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment